Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents

Ann Oncol. 2023 Jun;34(6):557-563. doi: 10.1016/j.annonc.2023.02.015. Epub 2023 Mar 21.
No abstract available

Keywords: Clinical Practice Guideline; Lu-PSMA; abiraterone–prednisone; cabazitaxel; darolutamide; prostate cancer.

Publication types

  • Practice Guideline

MeSH terms

  • Humans
  • Male
  • Prostate-Specific Antigen
  • Prostatic Neoplasms* / drug therapy
  • Prostatic Neoplasms, Castration-Resistant* / drug therapy
  • Treatment Outcome


  • Prostate-Specific Antigen